Updates on the use of zanubrutinib in WM patients intolerant to ibrutinib or acalabrutinib VJHemOnc – Video Journal of Hematology & HemOnc 0:57 2 years ago 80 Далее Скачать
Safety and efficacy of zanubrutinib in patients who are intolerant to ibrutinib and/or acalabrutinib VJHemOnc – Video Journal of Hematology & HemOnc 1:33 1 year ago 253 Далее Скачать
Zanubrutinib for ibrutinib/acalabrutinib intolerant R/R B-cell malignancies VJHemOnc – Video Journal of Hematology & HemOnc 1:33 4 years ago 358 Далее Скачать
Zanubrutinib in acalabrutinib-intolerant patients with various B-cell malignancies VJHemOnc – Video Journal of Hematology & HemOnc 1:33 2 years ago 255 Далее Скачать
The efficacy of zanubrutinib versus ibrutinib in patients with WM harboring various mutations VJHemOnc – Video Journal of Hematology & HemOnc 1:44 2 years ago 315 Далее Скачать
Emerging therapies for WM: acalabrutinib and zanubrutinib VJHemOnc – Video Journal of Hematology & HemOnc 3:28 3 years ago 271 Далее Скачать
Dr. Shadman presents on the use of Zanubrutinib in BTK Inhibitor-Intolerant Patients at ASH 2021 Fred Hutch Patient Care 1:29 3 years ago 126 Далее Скачать
Using Acalabrutinib in CLL Patients With Ibrutinib Intolerance Targeted Oncology 0:43 5 years ago 367 Далее Скачать
Safety and efficacy of zanubrutinib in patients with B-cell malignancies VJHemOnc – Video Journal of Hematology & HemOnc 2:44 3 years ago 685 Далее Скачать
Zanubrutinib and acalabrutinib for CLL: potential alternatives to ibrutinib? VJHemOnc – Video Journal of Hematology & HemOnc 3:19 5 years ago 2 296 Далее Скачать
Zanubrutinib in patients with B-cell malignancies who are acalabrutinib-intolerant VJHemOnc – Video Journal of Hematology & HemOnc 1:06 10 months ago 114 Далее Скачать
Tolerability of next-generation BTK inhibitors: acalabrutinib, zanubrutinib and pirtobrutinib VJHemOnc – Video Journal of Hematology & HemOnc 3:31 1 year ago 1 269 Далее Скачать
ASPEN: zanubrutinib versus ibrutinib in patients with WM VJHemOnc – Video Journal of Hematology & HemOnc 6:05 4 years ago 300 Далее Скачать
Selecting between ibrutinib, acalabrutinib and zanubrutinib in the frontline setting in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:57 1 year ago 2 340 Далее Скачать
Zanubrutinib improves PFS compared to ibrutinib for R/R CLL and small lymphocytic lymphoma ecancer 4:14 1 year ago 379 Далее Скачать
Dr. Dimopoulos on the Safety of Zanubrutinib Versus Ibrutinib in Waldenström Macroglobulinemia OncLive 1:01 4 years ago 541 Далее Скачать
Timely Updates in the Treatment of Waldenstrom's Macroglobulinemia-Zanubrutinib International Waldenstrom's Macroglobulinemia Foundation 45:34 3 years ago 3 431 Далее Скачать
Zanubrutinib demonstrates superior PFS compared with ibrutinib for treatment of R/R CLL and SLL ecancer 6:45 1 year ago 236 Далее Скачать
Health-related quality of life with zanubrutinib versus ibrutinib for patients with R/R CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:20 1 year ago 582 Далее Скачать
FDA approves Zanubrutinib for patients with Waldenström’s Macroglobulinemia MedSynapse 4:53 3 years ago 70 Далее Скачать